SAB Meeting 2025 Reinforces Scientific Strategy of iBET
A key moment for the iBET community to reflect on future challenges and opportunities
On July 11, iBET had the pleasure of welcoming its International Scientific Advisory Board (SAB) to the annual meeting, held at the iBET Biofarma (Oeiras).
Over the past 35 years, iBET has been privileged to benefit from the guidance and support of a distinguished group of experts from the global pharmaceutical and biotechnology industries. These long-standing and trusted relationships have played a role in shaping iBET’s strategic direction, elevating its scientific profile, and fostering continued growth and innovation.
This one-day meeting is an important event for the institution, offering a valuable opportunity to review the year’s scientific achievements, business development highlights, and to discuss future strategies and their implementation. As in previous years, the SAB meeting also serves as an important moment to reflect on upcoming challenges and opportunities, and to ensure alignment with current trends and demands in both science and business.
The insights and recommendations shared by the SAB members continue to be instrumental and the Leadership team extends its acknowledgement to Dr. Clive Wood (iBET SAB Chairman), Dr. Hitto Kaufmann, Dr. Chetan Goudar, Dr. John Aunins, and Dr. Gargi Maheshwari, whom we had the pleasure of welcoming at iBET for the first time.
